Ann: Trading Halt, page-16

This is now a management action what will be told this week. Research is strongly supporting that Prana's safe iron chelator (PBT434) has good possibilities to help neurodegeneration patients as PD and AD patients. Now the management needs to do everything possible to get PBT434 to benefit the patients and owners of Prana. Dilution of our ownership could be a very positive thing if it helps Prana to get to the goal. I cannot see how this could be negative to us if the action will help Prana to get to the goal.